IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v15y2024i1d10.1038_s41467-024-46594-0.html
   My bibliography  Save this article

The bone ecosystem facilitates multiple myeloma relapse and the evolution of heterogeneous drug resistant disease

Author

Listed:
  • Ryan T. Bishop

    (H. Lee Moffitt Cancer Center and Research Institute)

  • Anna K. Miller

    (H. Lee Moffitt Cancer Center and Research Institute)

  • Matthew Froid

    (H. Lee Moffitt Cancer Center and Research Institute
    University of South Florida)

  • Niveditha Nerlakanti

    (H. Lee Moffitt Cancer Center and Research Institute
    University of South Florida)

  • Tao Li

    (H. Lee Moffitt Cancer Center and Research Institute)

  • Jeremy S. Frieling

    (H. Lee Moffitt Cancer Center and Research Institute)

  • Mostafa M. Nasr

    (H. Lee Moffitt Cancer Center and Research Institute
    University of South Florida)

  • Karl J. Nyman

    (H. Lee Moffitt Cancer Center and Research Institute
    University of South Florida)

  • Praneeth R. Sudalagunta

    (H. Lee Moffitt Cancer Center and Research Institute)

  • Rafael R. Canevarolo

    (H. Lee Moffitt Cancer Center and Research Institute)

  • Ariosto Siqueira Silva

    (H. Lee Moffitt Cancer Center and Research Institute)

  • Kenneth H. Shain

    (H. Lee Moffitt Cancer Center and Research Institute
    H. Lee Moffitt Cancer Center and Research Institute)

  • Conor C. Lynch

    (H. Lee Moffitt Cancer Center and Research Institute)

  • David Basanta

    (H. Lee Moffitt Cancer Center and Research Institute)

Abstract

Multiple myeloma (MM) is an osteolytic malignancy that is incurable due to the emergence of treatment resistant disease. Defining how, when and where myeloma cell intrinsic and extrinsic bone microenvironmental mechanisms cause relapse is challenging with current biological approaches. Here, we report a biology-driven spatiotemporal hybrid agent-based model of the MM-bone microenvironment. Results indicate MM intrinsic mechanisms drive the evolution of treatment resistant disease but that the protective effects of bone microenvironment mediated drug resistance (EMDR) significantly enhances the probability and heterogeneity of resistant clones arising under treatment. Further, the model predicts that targeting of EMDR deepens therapy response by eliminating sensitive clones proximal to stroma and bone, a finding supported by in vivo studies. Altogether, our model allows for the study of MM clonal evolution over time in the bone microenvironment and will be beneficial for optimizing treatment efficacy so as to significantly delay disease relapse.

Suggested Citation

  • Ryan T. Bishop & Anna K. Miller & Matthew Froid & Niveditha Nerlakanti & Tao Li & Jeremy S. Frieling & Mostafa M. Nasr & Karl J. Nyman & Praneeth R. Sudalagunta & Rafael R. Canevarolo & Ariosto Siquei, 2024. "The bone ecosystem facilitates multiple myeloma relapse and the evolution of heterogeneous drug resistant disease," Nature Communications, Nature, vol. 15(1), pages 1-18, December.
    • Handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-46594-0
    DOI: 10.1038/s41467-024-46594-0
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-024-46594-0
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-024-46594-0?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Michelle A. Lawson & Michelle M. McDonald & Natasa Kovacic & Weng Hua Khoo & Rachael L. Terry & Jenny Down & Warren Kaplan & Julia Paton-Hough & Clair Fellows & Jessica A. Pettitt & T. Neil Dear & Els, 2015. "Osteoclasts control reactivation of dormant myeloma cells by remodelling the endosteal niche," Nature Communications, Nature, vol. 6(1), pages 1-15, December.
    2. Javad Salimi Sartakhti & Mohammad Hossein Manshaei & Soroosh Bateni & Marco Archetti, 2016. "Evolutionary Dynamics of Tumor-Stroma Interactions in Multiple Myeloma," PLOS ONE, Public Library of Science, vol. 11(12), pages 1-17, December.
    3. Jeremy J. McGuire & Jeremy S. Frieling & Chen Hao Lo & Tao Li & Ayaz Muhammad & Harshani R. Lawrence & Nicholas J. Lawrence & Leah M. Cook & Conor C. Lynch, 2021. "Mesenchymal stem cell-derived interleukin-28 drives the selection of apoptosis resistant bone metastatic prostate cancer," Nature Communications, Nature, vol. 12(1), pages 1-13, December.
    4. Robert Vander Velde & Nara Yoon & Viktoriya Marusyk & Arda Durmaz & Andrew Dhawan & Daria Miroshnychenko & Diego Lozano-Peral & Bina Desai & Olena Balynska & Jan Poleszhuk & Liu Kenian & Mingxiang Ten, 2020. "Resistance to targeted therapies as a multifactorial, gradual adaptation to inhibitor specific selective pressures," Nature Communications, Nature, vol. 11(1), pages 1-13, December.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Marco Archetti, 2018. "How to Analyze Models of Nonlinear Public Goods," Games, MDPI, vol. 9(2), pages 1-15, April.
    2. Javad Salimi Sartakhti & Mohammad Hossein Manshaei & Marco Archetti, 2018. "Game Theory of Tumor–Stroma Interactions in Multiple Myeloma: Effect of Nonlinear Benefits," Games, MDPI, vol. 9(2), pages 1-11, May.
    3. Javad Salimi Sartakhti & Mohammad Hossein Manshaei & David Basanta & Mehdi Sadeghi, 2017. "Evolutionary emergence of angiogenesis in avascular tumors using a spatial public goods game," PLOS ONE, Public Library of Science, vol. 12(4), pages 1-17, April.
    4. Karin Schmelz & Joern Toedling & Matt Huska & Maja C. Cwikla & Louisa-Marie Kruetzfeldt & Jutta Proba & Peter F. Ambros & Inge M. Ambros & Sengül Boral & Marco Lodrini & Celine Y. Chen & Martin Burker, 2021. "Spatial and temporal intratumour heterogeneity has potential consequences for single biopsy-based neuroblastoma treatment decisions," Nature Communications, Nature, vol. 12(1), pages 1-13, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-46594-0. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.